Let’s talk cost effectiveness.

In this interesting single arm phase 2 study, 30 patients with oligometastatic renal cell carcinoma with a history of new more than one prior systemic therapy received “serial definitive radiation” to all current and subsequent sites of disease (as long as total number was limited to 5) instead of any systemic therapy, with no deaths and only 7 patients requiring initiation of systemic therapy at last follow-up. | Tang, Lancet Oncol 2021


Popular Posts